drugset / Trial / NCT04454476
Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor
NaSingle-groupOpen-labelTreatment
Summary
This is a study of the safety and effectiveness of Trametinib treatment in patients who have received successful endoscopic submucosal resection of a Stage I gastric cancer.
Timeline
- Start
- 2022-11-09
- Primary completion
- 2024-12
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trametinib | Small molecule | 1 mg | Oral |